PLRX - Pliant Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PLRX is currently covered by 3 analysts with an average price target of $2.67. This is a potential upside of $1.62 (154.29%) from yesterday's end of day stock price of $1.05.

Pliant Therapeutics's activity chart (see below) currently has 150 price targets and 129 ratings on display. The stock rating distribution of PLRX is 66.67% HOLD and 33.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.11% with an average time for these price targets to be met of 70.04 days.

Highest price target for PLRX is $3, Lowest price target is $2, average price target is $2.67.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 13-Mar-2026. First documented stock forecast 29-Jun-2020.

Best performing analysts who are covering PLRX - Pliant Therapeutics:

Pete Stavropoulos David Lebowitz Mike Kratky

Currently out of the existing stock ratings of PLRX, 2 are a HOLD (66.67%), 1 are a BUY (33.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Mar-2026

$3

$1.92 (177.78%)

6 months 19 days ago
(13-Mar-2026)

0/4 (0%)

$1.65 (122.22%)

Buy Since 22-Apr-2021

$3

$1.92 (177.78%)

$4

6 months 20 days ago
(12-Mar-2026)

0/7 (0%)

$1.59 (112.77%)

Hold Since 04-Mar-2025

$2

$0.92 (85.19%)

10 months 25 days ago
(07-Nov-2025)

1/17 (5.88%)

$0.4 (25.00%)

227

Hold Since 04-Mar-2025

$1.7

$0.62 (57.41%)

$1.5

1 years 1 months 24 days ago
(08-Aug-2025)

3/8 (37.5%)

$0.04 (2.41%)

51

Hold Since 10-Feb-2025

1 years 6 months 14 days ago
(18-Mar-2025)

0/21 (0%)

$23.49 (161.89%)

Show more analysts

Please expand the browser size to see the chart

What is PLRX (Pliant Therapeutics) average time for price targets to be met?

On average it took 70 days for the stock forecasts to be reached, with an average price target met ratio of 13.11%.

Which analyst most recently updated their price target on PLRX (Pliant Therapeutics)?

Edward Nash

Which analyst has the most public recommendations on PLRX (Pliant Therapeutics)?

Edward Nash works at CANACCORD and has 6 price targets and 4 ratings on PLRX

Which analyst is the currently most bullish on PLRX (Pliant Therapeutics)?

Julian Harrison with the highest potential upside of $49.83

Which analyst is the currently most reserved on PLRX (Pliant Therapeutics)?

Pete Stavropoulos with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?